EMEA-003176-PIP02-22
Submitted by Anonymous (not verified) on 13 May 2025 - 14:44
EMEA-003176-PIP02-22
European Shortages Monitoring Platform (ESMP) essentials: Industry and network reporting requirements
Submitted by Anonymous (not verified) on 13 May 2025 - 14:17
European Shortages Monitoring Platform (ESMP) essentials: Industry and network reporting requirements
European Shortages Monitoring Platform (ESMP) Informational brief
Submitted by Anonymous (not verified) on 13 May 2025 - 14:15
European Shortages Monitoring Platform (ESMP) Informational brief
Amended Biologics Working Party Vaccines Quality Operational Expert Group (BV-OEG) Influenza Meeting: EU recommendations for the seasonal influenza vaccine composition for the season 2025/2026
Submitted by Anonymous (not verified) on 13 May 2025 - 14:00
Amended Biologics Working Party Vaccines Quality Operational Expert Group (BV-OEG) Influenza Meeting: EU recommendations for the seasonal influenza vaccine composition for the season 2025/2026
Human medicines European public assessment report (EPAR): Actelsar HCT, telmisartan,hydrochlorothiazide, Date of authorisation: 13/03/2013, Revision: 19, Status: Authorised
Submitted by Anonymous (not verified) on 13 May 2025 - 13:30
Human medicines European public assessment report (EPAR): Actelsar HCT, telmisartan,hydrochlorothiazide, Date of authorisation: 13/03/2013, Revision: 19, Status: Authorised
Frequently asked questions on the European Shortages Monitoring Platform (ESMP)
Submitted by Anonymous (not verified) on 13 May 2025 - 13:25
Frequently asked questions on the European Shortages Monitoring Platform (ESMP)
Human medicines European public assessment report (EPAR): Enbrel, etanercept, Date of authorisation: 02/02/2000, Revision: 75, Status: Authorised
Submitted by Anonymous (not verified) on 13 May 2025 - 13:18
Human medicines European public assessment report (EPAR): Enbrel, etanercept, Date of authorisation: 02/02/2000, Revision: 75, Status: Authorised
Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 13 May 2025 - 13:07
Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Revision: 2, Status: Authorised
Network Data Steering Group workplan 2025-2028
Submitted by Anonymous (not verified) on 13 May 2025 - 12:54
Network Data Steering Group workplan 2025-2028
European Shortages Monitoring Platform (ESMP): Implementation guide for national competent authorities
Submitted by Anonymous (not verified) on 13 May 2025 - 11:00
European Shortages Monitoring Platform (ESMP): Implementation guide for national competent authorities